Stephen K. M.d. Klasko - 12 Nov 2024 Form 4 Insider Report for DocGo Inc. (DCGO)

Reporting relationship: Director
Issuer ticker: DCGO
Reported as of: 12 Nov 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Nov 2024, 17:23:36 UTC
Prior SEC filing: 01 Oct 2024
Next SEC filing: 21 Feb 2025
Source filing: View source filing
Reporting owner signature: Jerilyn Laskie, as Attorney-in-Fact for Stephen K. Klasko, MD

Key filing fact

Stephen K. M.d. Klasko filed Form 4 for DocGo Inc. (DCGO) on 14 Nov 2024.

Key facts

This page summarizes Stephen K. M.d. Klasko's Form 4 filing for DocGo Inc. (DCGO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Nov 2024, 17:23.

Change

Previous filing in this sequence was filed on 01 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DCGO transaction Derivative

Options to purchase Common Stock

Award

Transaction value: $0
Shares: +204,082
Change %
Price: $0.000000
Shares after: 204,082
Date: 12 Nov 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 204,082
Exercise price: $4.16
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents options granted under the DocGo Inc. 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

Footnote F2

The reported options will vest and become exercisable on the first anniversary of the grant date, subject to the terms of the Plan.